Therefore, in clinical practice, monitoring IL-6 can detect risks earlier in patients with severe pneumonia suspected of having bloodstream infections; if combined with HBP (for evaluating microcirculation) and SOFA score (for evaluating organ damage), a more comprehensive understanding of the patient’s infection status and immune status can be obtained, avoiding the limitations of a single indicator. The gene discussed is IL6; the disease is susceptibility to pneumonia measurement.